<DOC>
	<DOCNO>NCT01189864</DOCNO>
	<brief_summary>The purpose study evaluate efficacy ultraviolet-A ( UVA ) -induced cross-linking corneal collagen ( CXL ) method increase biomechanical biochemical stability cornea induce additional cross-link within collagen fiber use UVA light photo- mediator riboflavin . The purpose study generate data presentation medical meeting peer-review publication . The data generate study submit FDA support commercialization riboflavin drop .</brief_summary>
	<brief_title>Cross-linking Corneal Collagen ( CXL ) With Ultraviolet-A Asymmetric Corneas</brief_title>
	<detailed_description />
	<mesh_term>Keratoconus</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Fluorometholone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>12 year age old Diagnosis keratoconus , FFKC , postLASIK ectasia , pellucid marginal degeneration forme fruste pellucid marginal degeneration ( FFPMD ) . Diagnosis FFKC History Radial Keratotomy fluctuate vision Ability provide write informed consent Likely complete study visit Minimum corneal thickness least 300 Measured ultrasound Pentacam At least 6 month since last corneal surgery ( Intacs/PRK/LASIK/EpiLASIK/LASEK ) Severe corneal scar markedly affect vision Contraindications study medication component Pregnancy breast feed Active Herpes Corneal Disease</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>